Back to Top Skip to main content

Mobility Airmen conduct historic first aeromedical evacuation mission using Transport Isolation System

Image of three people exiting an aircraft Three U.S. Air Force medical Airmen exit a C-17 Globemaster III aircraft following the first-ever operational use of the Transport Isolation System at Ramstein Air Base, Germany, April 10, 2020. The TIS is an infectious disease containment unit designed to minimize contamination risk to aircrew and medical attendants, while allowing in-flight medical care for patients afflicted by a disease--in this case, COVID-19. (U.S. Air Force photo by Staff Sgt. Devin Nothstine)

Recommended Content:

Coronavirus | Global Health Engagement | Global Health Engagement

RAMSTEIN AIR BASE, Germany – Air Mobility Command aircrew and medical personnel conducted the first operational use of the Transport Isolation System (TIS) to perform an aeromedical evacuation of three U.S. government contractors who tested positive for Coronavirus, from Afghanistan to Ramstein Air Base, Germany, April 10. Upon arrival at Ramstein, the patients were transferred to Landstuhl Regional Medical Center for medical treatment.

The AE mission, REACH 725, marked the first operational use of the TIS since its development during the 2014 Ebola outbreak in West Africa, and the first movement of COVID-19 positive patients aboard U.S. Air Force aircraft. The TIS is an infectious disease containment unit designed to minimize risk to aircrew, medical attendants, and the airframe, while allowing medical care to be provided to patients in-flight.

REACH 725 was comprised of a full TIS force package, which includes one C-17 and aircrew carrying two TIS modules and medical support personnel, consisting of AE specialists, Critical Care Air Transport Team (CCATT) members, infectious diseases doctors and technicians, and TIS operators.

Upon receipt of a warning order from U.S. Transportation Command April 8, the 618th Air Operations Center tasked a TIS-trained AMC aircrew and medical team at Ramstein AB to prepare to execute the mission within 24 hours. Drawn from multiple specialties and units from across the Air Force, these Airmen were pre-staged with a Joint Base Charleston C-17 and TIS at Ramstein’s 86th Airlift Wing in late March in anticipation of Joint Force, Allied and partner requirements in Europe, Africa and the Middle East. Since arriving, these Airmen have trained to increase proficiency on the movement of infectious patients via the TIS.

“Our unique capabilities paired with our strategic locations across the globe enable us to rapidly help those in need,” said Air Force Gen. Jeff Harrigian, commander of U.S. Air Forces in Europe-Air Forces Africa and NATO Allied Air Command. “Along with our allies and partners we stand united against a shared threat and stand ready to help when called.”

Hours before the crew stepped to the C-17, Air Force Brig. Gen. Jimmy Canlas, 618th AOC commander, led a teleconference call in which he provided them with clear guidance in line with the recently released AMC COVID-19 Patient Movement Plan.

“Through the meticulous effort of AMC’s planners over the past few weeks, in coordination with U.S. Transportation Command, we’ve produced a detailed plan that guides our crews on how to safely and effectively move ill patients to a location where they can receive greater care, all while providing protection for our aircrew, medical personnel and aircraft,” said Canlas. “Within hours of completing and releasing this plan to the force, the crew of REACH 725 validated the hard work of these planners by safely transporting three COVID-19 patients nearly 4,000 miles from Afghanistan to Landstuhl.”

Developed by AMC planners over the past few weeks, the PMP provides aircrew and support personnel a comprehensive and detailed process by which to transport patients aboard pressurized, military aircraft, including patients afflicted with highly contagious diseases like COVID-19.

“I’m exceptionally proud of our Airmen who executed this historic AE mission,” said Air Force Gen. Maryanne Miller, AMC commander. “REACH 725 is a great demonstration of AMC’s transition to a warfighting component command, with increased flexibility and speed enabling our Mobility Airmen to quickly answer any call for help during this global campaign to defeat COVID-19.  Delivering hope runs deep in the blood of Mobility Airmen, and I’m in awe of what they are doing for those in need.”

Read more about the Transport Isolation System here: https://www.amc.af.mil/About-Us/Fact-Sheets/Display/Article/2132917/transport-isolation-system-tis/.

Disclaimer: Re-published content may be edited for length and clarity. Read original post.

You also may be interested in...

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DoD Instruction 2000.30: Global Health Engagement Activities

Policy

This instruction establishes policy, assigns responsibilities, and prescribes procedures for the conduct of global health engagement activities with partner nation (PN) entities.

Japanese Encephalitis (JE) virus is a mosquito-borne flavivirus and the most common vaccine-preventable cause of encephalitis in Asia

Policy

Individuals deploying to areas in Pacific Command (PACOM) should be administered the JE vaccine in accordance with the latest PACOM Force Health Protection Guidance.

Guidance on Medications for Prophylaxis of Malaria 13-002

Policy

This document provides guidance and best practices for the chemoprophylaxis (use of medication to prevent malaria) of Service members serving in malaria endemic regions.

MHS Training Directive for Medical Stability Operations

Policy

MHS Training Directive for Medical Stability Operations

Joint Pub 3-07, Stability Operations, September 29, 2011

Policy

DoD Support to Foreign Disaster Relief Handbook

Policy

DoD Support to Foreign Disaster Relief Handbook

Showing results 1 - 14 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.